These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23177281)

  • 1. Hepatitis C virus viral assays in the direct-acting antiviral era.
    Vierling JM
    Clin Liver Dis; 2013 Feb; 17(1):27-45. PubMed ID: 23177281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV RNA viral load assessments in the era of direct-acting antivirals.
    Cobb B; Pockros PJ; Vilchez RA; Vierling JM
    Am J Gastroenterol; 2013 Apr; 108(4):471-5. PubMed ID: 23552304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4.
    Rivero-Juárez A; Camacho Espejo A; Perez-Camacho I; Neukam K; Caruz A; Mira JA; Mesa P; García-Lázaro M; Torre-Cisneros J; Pineda JA; Rivero A
    J Antimicrob Chemother; 2012 Jan; 67(1):202-5. PubMed ID: 21990051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
    Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
    New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host and viral determinants of the outcome of exposure to HCV infection genotype 4: a large longitudinal study.
    Kamal SM; Kassim SK; Ahmed AI; Mahmoud S; Bahnasy KA; Hafez TA; Aziz IA; Fathelbab IF; Mansour HM
    Am J Gastroenterol; 2014 Feb; 109(2):199-211. PubMed ID: 24445571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that predict response of patients with hepatitis C virus infection to boceprevir.
    Poordad F; Bronowicki JP; Gordon SC; Zeuzem S; Jacobson IM; Sulkowski MS; Poynard T; Morgan TR; Molony C; Pedicone LD; Sings HL; Burroughs MH; Sniukiene V; Boparai N; Goteti VS; Brass CA; Albrecht JK; Bacon BR;
    Gastroenterology; 2012 Sep; 143(3):608-618.e5. PubMed ID: 22626609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The diagnosis of hepatitis C virus infection].
    Gervain J
    Orv Hetil; 2014 Jun; 155(26):1019-23. PubMed ID: 24954143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to direct antiviral agents in patients with hepatitis C virus infection.
    Sarrazin C; Zeuzem S
    Gastroenterology; 2010 Feb; 138(2):447-62. PubMed ID: 20006612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis C Virus.
    Wei B; Kang J; Kibukawa M; Chen L; Qiu P; Lahser F; Marton M; Levitan D
    J Mol Diagn; 2016 Sep; 18(5):643-656. PubMed ID: 27393904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents.
    Kalaghatgi P; Sikorski AM; Knops E; Rupp D; Sierra S; Heger E; Neumann-Fraune M; Beggel B; Walker A; Timm J; Walter H; Obermeier M; Kaiser R; Bartenschlager R; Lengauer T
    PLoS One; 2016; 11(5):e0155869. PubMed ID: 27196673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.
    Mangia A; Thompson AJ; Santoro R; Piazzolla V; Tillmann HL; Patel K; Shianna KV; Mottola L; Petruzzellis D; Bacca D; Carretta V; Minerva N; Goldstein DB; McHutchison JG
    Gastroenterology; 2010 Sep; 139(3):821-7, 827.e1. PubMed ID: 20621700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of HCV RNA monitoring in the era of new potent therapies.
    Wiesmann F; Braun P
    Expert Rev Anti Infect Ther; 2016 Sep; 14(9):837-44. PubMed ID: 27424603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples.
    Zhang EZ; Bartels DJ; Frantz JD; Seepersaud S; Lippke JA; Shames B; Zhou Y; Lin C; Kwong A; Kieffer TL
    Virol J; 2013 Feb; 10():53. PubMed ID: 23402332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genotype independent, full-genome reverse-transcription protocol for HCV genotyping and resistance testing.
    Walker A; Bergmann M; Camdereli J; Kaiser R; Lübke N; Timm J
    J Clin Virol; 2017 Jun; 91():42-48. PubMed ID: 28463753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDLr genotype modifies the impact of IL28B on HCV viral kinetics after the first weeks of treatment with PEG-IFN/RBV in HIV/HCV patients.
    Rivero-Juarez A; Camacho A; Caruz A; Neukam K; Gonzalez R; Di Lello FA; Perez-Camacho I; Mesa P; Torre-Cisneros J; Peña J; Pineda JA; Rivero A
    AIDS; 2012 May; 26(8):1009-15. PubMed ID: 22382144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Treatment of Untypable HCV Variants in Different Districts of Punjab, Pakistan.
    Zafar A; Imran M; Zahoor S; Shah ZH; Ali M; Afzal MS
    Viral Immunol; 2018; 31(6):426-432. PubMed ID: 29920175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
    Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
    J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the predictors of a sustained virologic response in the era of direct-acting antiviral therapy for hepatitis C virus.
    Beinhardt S; Rutter K; Stättermayer AF; Ferenci P
    Clin Infect Dis; 2013 Jan; 56(1):118-22. PubMed ID: 23024292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexities of HCV management in the new era of direct-acting antiviral agents.
    Rosenberg WM; Tanwar S; Trembling P
    QJM; 2014 Jan; 107(1):17-9. PubMed ID: 24065837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and clinical performance of the Hologic Aptima HCV Quant Dx Assay for the quantification of HCV RNA in plasma samples.
    Schønning K; Pedersen MS; Johansen K; Landt B; Nielsen LG; Weis N; Westh H
    J Virol Methods; 2017 Oct; 248():159-165. PubMed ID: 28732692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.